Hedge Fund - Eversept Partners
United Therapeutics Corp (UTHR)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2025 - Q1 (2025-03-31) | $17,722,134 | 1.8% | 57,489 | $342.70 |
2 | 2024 - Q4 (2024-12-31) | $15,420,167 | 1.36% | 43,703 | $367.56 |
3 | 2024 - Q3 (2024-09-30) | $46,925,574 | 3.21% | 130,949 | $337.80 |
4 | 2024 - Q2 (2024-06-30) | $74,971,061 | 5.13% | 235,351 | $264.67 |
5 | 2024 - Q1 (2024-03-31) | $57,690,732 | 3.84% | 251,135 | $225.66 |
6 | 2023 - Q4 (2023-12-31) | $54,144,394 | 4.75% | 246,234 | $230.49 |
7 | 2023 - Q3 (2023-09-30) | $60,511,251 | 5.12% | 267,903 | $230.33 |
8 | 2023 - Q2 (2023-06-30) | $57,482,859 | 4.8% | 260,398 | $221.53 |
9 | 2023 - Q1 (2023-03-31) | $49,743,084 | 3.46% | 222,107 | $246.53 |
10 | 2022 - Q4 (2022-12-31) | $64,735,737 | 5.66% | 232,787 | $252.44 |
11 | 2022 - Q3 (2022-09-30) | $53,439,220 | 4.63% | 255,226 | $223.56 |
12 | 2022 - Q2 (2022-06-30) | $73,244,924 | 5.2% | 310,834 | $203.30 |
13 | 2022 - Q1 (2022-03-31) | $52,429,702 | 4.02% | 292,234 | $190.51 |
14 | 2021 - Q4 (2021-12-31) | $84,686,074 | 5.4% | 391,920 | $196.31 |
15 | 2021 - Q3 (2021-09-30) | $82,040,457 | 5.67% | 444,471 | $196.97 |
16 | 2021 - Q2 (2021-06-30) | $79,468,762 | 5.29% | 442,945 | $190.45 |
17 | 2021 - Q1 (2021-03-31) | $81,381,706 | 6.11% | 486,529 | $166.73 |
18 | 2020 - Q4 (2020-12-31) | $69,616,358 | 8.16% | 458,636 | $131.23 |
19 | 2020 - Q3 (2020-09-30) | $24,331,304 | 5.4% | 240,904 | $109.73 |
20 | 2020 - Q2 (2020-06-30) | $28,153,796 | 3.86% | 232,676 | $112.52 |
The displayed share prices are average quarterly stock market prices.